Cargando…

Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer

Reciprocal chromosomal translocations (RCTs) leading to the formation of fusion genes are important drivers of hematological cancers. Although the general requirements for breakage and fusion are fairly well understood, quantitative support for a general mechanism of RCT formation is still lacking....

Descripción completa

Detalles Bibliográficos
Autores principales: Shugay, Mikhail, Ortiz de Mendíbil, Iñigo, Vizmanos, José L., Novo, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516532/
https://www.ncbi.nlm.nih.gov/pubmed/23236267
http://dx.doi.org/10.1371/journal.pcbi.1002797
_version_ 1782252319536054272
author Shugay, Mikhail
Ortiz de Mendíbil, Iñigo
Vizmanos, José L.
Novo, Francisco J.
author_facet Shugay, Mikhail
Ortiz de Mendíbil, Iñigo
Vizmanos, José L.
Novo, Francisco J.
author_sort Shugay, Mikhail
collection PubMed
description Reciprocal chromosomal translocations (RCTs) leading to the formation of fusion genes are important drivers of hematological cancers. Although the general requirements for breakage and fusion are fairly well understood, quantitative support for a general mechanism of RCT formation is still lacking. The aim of this paper is to analyze available high-throughput datasets with computational and robust statistical methods, in order to identify genomic hallmarks of translocation partner genes (TPGs). Our results show that fusion genes are generally overexpressed due to increased promoter activity of 5′ TPGs and to more stable 3′-UTR regions of 3′ TPGs. Furthermore, expression profiling of 5′ TPGs and of interaction partners of 3′ TPGs indicates that these features can help to explain tissue specificity of hematological translocations. Analysis of protein domains retained in fusion proteins shows that the co-occurrence of specific domain combinations is non-random and that distinct functional classes of fusion proteins tend to be associated with different components of the gene fusion network. This indicates that the configuration of fusion proteins plays an important role in determining which 5′ and 3′ TPGs will combine in specific fusion genes. It is generally accepted that chromosomal proximity in the nucleus can explain the specific pairing of 5′ and 3′ TPGS and the recurrence of hematological translocations. Using recently available data for chromosomal contact probabilities (Hi-C) we show that TPGs are preferentially located in early replicated regions and occupy distinct clusters in the nucleus. However, our data suggest that, in general, nuclear position of TPGs in hematological cancers explains neither TPG pairing nor clinical frequency. Taken together, our results support a model in which genomic features related to regulation of expression and replication timing determine the set of candidate genes more likely to be translocated in hematological tissues, with functional constraints being responsible for specific gene combinations.
format Online
Article
Text
id pubmed-3516532
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35165322012-12-12 Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer Shugay, Mikhail Ortiz de Mendíbil, Iñigo Vizmanos, José L. Novo, Francisco J. PLoS Comput Biol Research Article Reciprocal chromosomal translocations (RCTs) leading to the formation of fusion genes are important drivers of hematological cancers. Although the general requirements for breakage and fusion are fairly well understood, quantitative support for a general mechanism of RCT formation is still lacking. The aim of this paper is to analyze available high-throughput datasets with computational and robust statistical methods, in order to identify genomic hallmarks of translocation partner genes (TPGs). Our results show that fusion genes are generally overexpressed due to increased promoter activity of 5′ TPGs and to more stable 3′-UTR regions of 3′ TPGs. Furthermore, expression profiling of 5′ TPGs and of interaction partners of 3′ TPGs indicates that these features can help to explain tissue specificity of hematological translocations. Analysis of protein domains retained in fusion proteins shows that the co-occurrence of specific domain combinations is non-random and that distinct functional classes of fusion proteins tend to be associated with different components of the gene fusion network. This indicates that the configuration of fusion proteins plays an important role in determining which 5′ and 3′ TPGs will combine in specific fusion genes. It is generally accepted that chromosomal proximity in the nucleus can explain the specific pairing of 5′ and 3′ TPGS and the recurrence of hematological translocations. Using recently available data for chromosomal contact probabilities (Hi-C) we show that TPGs are preferentially located in early replicated regions and occupy distinct clusters in the nucleus. However, our data suggest that, in general, nuclear position of TPGs in hematological cancers explains neither TPG pairing nor clinical frequency. Taken together, our results support a model in which genomic features related to regulation of expression and replication timing determine the set of candidate genes more likely to be translocated in hematological tissues, with functional constraints being responsible for specific gene combinations. Public Library of Science 2012-12-06 /pmc/articles/PMC3516532/ /pubmed/23236267 http://dx.doi.org/10.1371/journal.pcbi.1002797 Text en © 2012 Shugay et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Shugay, Mikhail
Ortiz de Mendíbil, Iñigo
Vizmanos, José L.
Novo, Francisco J.
Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title_full Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title_fullStr Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title_full_unstemmed Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title_short Genomic Hallmarks of Genes Involved in Chromosomal Translocations in Hematological Cancer
title_sort genomic hallmarks of genes involved in chromosomal translocations in hematological cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516532/
https://www.ncbi.nlm.nih.gov/pubmed/23236267
http://dx.doi.org/10.1371/journal.pcbi.1002797
work_keys_str_mv AT shugaymikhail genomichallmarksofgenesinvolvedinchromosomaltranslocationsinhematologicalcancer
AT ortizdemendibilinigo genomichallmarksofgenesinvolvedinchromosomaltranslocationsinhematologicalcancer
AT vizmanosjosel genomichallmarksofgenesinvolvedinchromosomaltranslocationsinhematologicalcancer
AT novofranciscoj genomichallmarksofgenesinvolvedinchromosomaltranslocationsinhematologicalcancer